الفهرس 
IntroductionOnly 14 pages are availabe for public view
 |  | from | 169 |  |  |
| | | from | 169 | | |
Abstract
Abstract
Background: ADHD is a common neurodevelopmental disorder
in children. Abnormal EEG findings with no clinical epilepsy is
a common finding in ADHD as compared to normal children.
The aim of this study was to assess the efficacy and tolerability
of carbamazepine (CBZ) in ADHD children who have abnormal
EEG findings.
Methods: 15 drug naïve ADHD children (13 boys, 2 girls; mean
age, 6.62 years; range 4-10) with EEG abnormalities but no
clinical seizures were included. All were treated with
carbamazepine (mean dose 5 mg/kg/day). They were followed
up through a period of 8 weeks for symptom improvement and
occurrence of side effects. Improvement was measured using
the parents form ADHD rating scale 4; before and after CBZ
treatment.
Results: there was statistically significant improvement in mean
ADHD RS scores specifically in the domains of inattention and
combined symptoms while there was no improvement in
hyperactivity scores.
Conclusion: low dose carbamazepine can be a well tolerated
and effective treatment in some cases of ADHD associated with
abnormal EEG findings.
Key words:
Attention deficit hyperactivity disorder, carbamazepine,
electroencephalography, ADHD rating scale